Cargando…
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
PURPOSE: Mucosal melanoma represents ~1% of all melanomas, frequently having a poor prognosis due to diagnosis at a late stage of disease. Mucosal melanoma differs from cutaneous melanoma not only in terms of poorer clinical outcome but also on the molecular level having e.g. less BRAF and more freq...
Autores principales: | Cosgarea, Ioana, Ugurel, Selma, Sucker, Antje, Livingstone, Elisabeth, Zimmer, Lisa, Ziemer, Mirjana, Utikal, Jochen, Mohr, Peter, Pfeiffer, Christiane, Pföhler, Claudia, Hillen, Uwe, Horn, Susanne, Schadendorf, Dirk, Griewank, Klaus G., Roesch, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522195/ https://www.ncbi.nlm.nih.gov/pubmed/28380455 http://dx.doi.org/10.18632/oncotarget.16542 |
Ejemplares similares
-
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic Melanoma
por: Placke, Jan-Malte, et al.
Publicado: (2021) -
Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
por: Albrecht, Lea Jessica, et al.
Publicado: (2022) -
TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Griewank, Klaus G., et al.
Publicado: (2013) -
Frequent Occurrence of NRAS and BRAF Mutations in Human Acral Naevi
por: Jansen, Philipp, et al.
Publicado: (2019) -
Lack of SF3B1 R625 mutations in cutaneous melanoma
por: Schilling, Bastian, et al.
Publicado: (2013)